Novonesis' Board of Directors has approved an inaugural multi-year share buyback program worth EUR 1 billion. The program is scheduled to begin during the second half of 2026 and is expected to finish by the end of 2029, subject to authorizations granted by the Annual General Meeting. Most of the shares acquired will be cancelled, while a smaller portion will be retained to satisfy obligations under employee share-based incentive programs. Novo Holdings, Novonesis' principal shareholder, intends to participate by selling shares and expects to retain an ownership interest of approximately 25.5% of the company's share capital after the repurchased shares are cancelled. The program will comply with the Market Abuse Regulation and the Safe Harbour Rules.